Dosing began at Weill Cornell Medical Center in a Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS.

In people with benign MS, there is a loss of overall brain tissue but other parts of the brain may grow to help compensate for the damage, a study suggests.

Multiple sclerosis (MS) includes both peripheral and central nervous system (CNS) inflammation, and an anti-inflammatory ...

Treating rare diseases can be complicated at the best of times, and it gets even more complicated when different patients ...

Systemic sclerosis (SSc) or scleroderma is a rare, chronic, autoimmune disorder that hardens connective tissue and muscle in ...

Multiple sclerosis (MS) affects an estimated 2.3 million people worldwide. Approximately 80% of people with MS have ...

Many patients with systemic sclerosis presented without the warning sign of Raynaud phenomenon as their initial symptom in an ...

Around one million Americans are living with multiple sclerosis, a disease that can change and even shorten lives.

Historically, optic nerve involvement has been excluded from MS diagnostic criteria, but its inclusion in the new iteration ...

ALS disease explained as Grey’s Anatomy star Eric Dane opens up about the very first symptom he experienced before receiving ...

Actor Eric Dane has opened up about his battle with amyotrophic lateral sclerosis (ALS) and is revealing the one symptom — ...

A school chef who has spent nearly two decades caring for his wife with multiple sclerosis has won over a $1 million lottery ...